Home / Research / Manufacturers / Dakocytomation California Inc Medical-device intelligence
Dakocytomation California Inc: FDA clearances and recalls Research Dakocytomation California Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
Names and coverage This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
Names observed in the source
Dakocytomation California Inc Dakocytomation California, Inc. Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.
Product codes in this company’s records Record activity in this scope 2 clearance records and 13 recall records in the covered releases, across 1 source company names and 4 product codes. Dated history runs from Feb 15, 2005 to Aug 15, 2006.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 15 matching records Device / record Company in FDA record Source Source date CYAN DXD, MULTITEST CD8/CD4/CD3, CD3-FITC, CD3-RPE, CD3-APC AND FLUOROSPHERES K060423 · GKZDakocytomation California, Inc. 510(k) Aug 15, 2006FDA decision date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0310-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0311-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0312--06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0313-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0314-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0315-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0316-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0317-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0318-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0319-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and… Z-0320-06 · NJTDakocytomation California Inc Recall Dec 23, 2005FDA classification date K 520411-2, Hercep Test, 35Test, HER2, Protein Z-0113-06 · MVCDakocytomation California Inc Recall Nov 1, 2005FDA classification date K 520711-2, Hercep Test, 35Test, HER2, Protein Z-0114-06 · MVCDakocytomation California Inc Recall Nov 1, 2005FDA classification date DAKOCYTOMATION ER/PR PHARMDX KIT K042884 · MXZDakocytomation California, Inc. 510(k) Feb 15, 2005FDA decision date
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗